Enduring Material

- https://bsmh.zoom.us/rec/share/ntV_EIevlr_JSZ0u0cWgDKUD_jRHxMPNoufxMILw9ZARZRx7RT-BWYz0GEjqptWX.mLZrPaSyeQ_XwyMw?startTime=1729347867000

• Describe how to integrate virtual care technologies into the management of substance use disorder to improve access to care and patient outcomes.
• Discuss motivational interviewing techniques to support personal growth and behavior change for patients with substance use disorders.
• Gain a comprehensive understanding of the legal landscape surrounding cannabis, including the status of legalization across different states, potential implications for clinical practice, and considerations for managing patients who use cannabis alongside other treatments.

• Bon Secours Mercy Health Center for Continuing Education designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
• Bon Secours Mercy Health Center for Continuing Education designates this enduring material for a maximum of 2 Hour(s) ACPE.
• Bon Secours Mercy Health Center for Continuing Education designates this enduring material for a maximum of 2 Hour(s) Attendance w/ No Credit.
• Bon Secours Mercy Health Center for Continuing Education designates this enduring material for a maximum of 2 Hour(s) APA. Participants should claim only the credit commensurate with the extent of their participation in the activity.
• As a Jointly Accredited Organization, Bon Secours Mercy Health Center for Continuing Education is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 2 continuing education credits.
• Bon Secours Mercy Health Center for Continuing Education designates this enduring material for a maximum of 2 Credit(s) IPCE.
• Bon Secours Mercy Health Center for Continuing Education designates this enduring material for a maximum of 2 Hour(s) NCPD (ANCC Contact Hours).

Successful completion of this CME activity enables the learner to earn credit toward the CME requirement(s) of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Additional references are included in the speaker slides and you can visit the Healthy State Alliance website at https://www.healthystatealliance.org/.
Note: for the panel discussion, you may need to refer to the slides in Recording #1. (AIN#4888)

Kevin Carmen, MD, Kevin Cooper, BS, Tracy Griffith, MD, Wesley Martus, MD, Herbert Schumm, MD, Vincent Vanek, MD, FACS, FASPEN, and Aaron Weiner, PhD, ABPP have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.

Trent Hall, DO has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• AstraZeneca - Consulting - Relationship Ended
• Lumanity - Advisory Committee Member - Relationship Ended

Any financial relationship that was found to be relevant has been mitigated.

Kevin Cooper, BS has indicated the presentation may include discussion of any off-label uses of a product. Explanation Given: We distribute Fentanyl and Xylazine test strips for clients to test their drugs for the presence of these substances. This was an off-label use of a urine dip test strip and considered drug paraphernalia under Ohio law until January 2023.

Victoria Cannon, BA, Cheryl Kuck, MS, CMA (AAMA), Melanie Woods, MSW, Dawn Mansfield, BSN, RN, Brian Latham, PharmD, Jennifer Lamanna, PhD, Herbert Schumm, MD, Jacob Stabler, Julie Teater, MD, and Mohammad Moinzadeh, LPCC have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.

This activity is not commercially supported.

75 %

100 %

1/1/2025